Oversight Committee Announces Schedule for the Week

Jul 22, 2019
Press Release

Washington, D.C. (July 22, 2019)—This week, the Committee on Oversight and Reform will convene a business meeting to hold White House officials accountable for their violations of law and a hearing to examine the gut-wrenching choices families make because of skyrocketing prescription drug prices.

Committee to Hold White House Officials Accountable for Violations of Federal Laws

Holding Kellyanne Conway in Contempt:  On Thursday, the Committee will hold a business meeting to hold Kellyanne Conway in contempt of Congress  for refusing to comply with a bipartisan subpoena requiring her testimony.  The independent Office of Special Counsel (OSC) issued a report finding that Conway repeatedly violated the Hatch Act.  OSC recommended that President Trump terminate Conway’s position, but he refused to impose any discipline at all.  The Committee previously held two hearings to attempt to obtain Conway’s testimony, including one under a subpoena, but she refused to appear.

Subpoenaing White House Emails:  The Committee will also vote to authorize the Chairman to subpoena records in the Committee’s investigation into the use of personal email and texting accounts for official business, which has been ongoing for more than two years under four different Republican and Democratic Chairmen.  The White House has refused to produce a single document or a single briefing in response to requests from Cummings. 

WHAT:                      Business Meeting

WHERE:                   2154 Rayburn House Office Building

WHEN:                      Thursday, July 25, 2019, at 10 am

A livestream of the business meeting will be available here.

Committee to Hold Hearing on Devastating Impacts of Skyrocketing Drug Prices on Patients

On Friday, the Committee will hold a hearing to examine the devastating impacts of drug companies’ price increases on the financial well-being and health of American patients who depend on prescription drugs.  Drug companies continue to raise prices, rake in record profits, and lavishly reward their executives and shareholders, all while stifling competition and preventing access to life-saving drugs.  Companies have raised prices on more than 3,400 drugs in 2019 alone, with an average price increase of five times the rate of inflation.  The Committee launched its wide-ranging investigation into the skyrocketing prices of prescription drugs in January.

WHAT:                      “The Patient Perspective:  The Devastating Impacts of Skyrocketing Drug Prices on  American Families”

WHERE:                   2154 Rayburn House Office Building

WHEN:                      Friday, July 26, 2019, at 9:30 am

WITNESSES:            Ashley Krege, Patient

                                    Sa’ra Skipper, Patient

                                    Pam Holt, Patient

                                    David Mitchell, Patient and Founder of Patients for Affordable Drugs

A livestream of the hearing will be available here.


116th Congress